HK132493A - Porphyrins and cancer treatment - Google Patents

Porphyrins and cancer treatment

Info

Publication number
HK132493A
HK132493A HK1324/93A HK132493A HK132493A HK 132493 A HK132493 A HK 132493A HK 1324/93 A HK1324/93 A HK 1324/93A HK 132493 A HK132493 A HK 132493A HK 132493 A HK132493 A HK 132493A
Authority
HK
Hong Kong
Prior art keywords
porphyrins
meso
same
cancer treatment
compound
Prior art date
Application number
HK1324/93A
Other languages
English (en)
Inventor
Raymond Prof Bonnett
Morris Cyril Dr Berenbaum
Original Assignee
Efamol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Ltd filed Critical Efamol Ltd
Publication of HK132493A publication Critical patent/HK132493A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK1324/93A 1984-11-26 1993-12-02 Porphyrins and cancer treatment HK132493A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848429845A GB8429845D0 (en) 1984-11-26 1984-11-26 Porphyrins & cancer treatment

Publications (1)

Publication Number Publication Date
HK132493A true HK132493A (en) 1993-12-10

Family

ID=10570288

Family Applications (1)

Application Number Title Priority Date Filing Date
HK1324/93A HK132493A (en) 1984-11-26 1993-12-02 Porphyrins and cancer treatment

Country Status (11)

Country Link
US (1) US4837221A (xx)
EP (1) EP0186962B1 (xx)
JP (1) JPH0653665B2 (xx)
AT (1) ATE42037T1 (xx)
AU (1) AU578329B2 (xx)
CA (1) CA1257202A (xx)
DE (1) DE3569332D1 (xx)
GB (1) GB8429845D0 (xx)
HK (1) HK132493A (xx)
IE (1) IE58500B1 (xx)
ZA (1) ZA858986B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
JPH0629196B2 (ja) * 1987-12-01 1994-04-20 甲子郎 梅村 超音波による腫瘍治療用生理作用増強剤
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
DE3809671A1 (de) * 1988-03-18 1989-09-28 Schering Ag Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH01242584A (ja) * 1988-03-24 1989-09-27 Yoshio Imai 芳香族ジアミン
FR2632187B1 (fr) * 1988-06-02 1990-09-14 Centre Nat Rech Scient Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides
FR2656866B1 (fr) * 1990-01-10 1992-05-15 Cis Bio Int Derives de porphyrine et metalloporphyrines eventuellement couples a une molecule biologiquement active, et composition pharmaceutique les contenant.
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
US5994339A (en) * 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
US6127356A (en) * 1993-10-15 2000-10-03 Duke University Oxidant scavengers
GB9408746D0 (en) * 1994-05-03 1994-06-22 Scotia Holdings Plc Tumour locallising photosensitising compounds
AU3758695A (en) * 1994-09-20 1996-04-09 Duke University Oxidoreductase activity of manganic porphyrins
AU725602B2 (en) * 1995-06-07 2000-10-12 Duke University Oxidant scavengers
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
ES2198767T3 (es) 1997-11-03 2004-02-01 Duke University Porfirinas sustituidas.
ATE311206T1 (de) 1998-04-24 2005-12-15 Univ Duke Substituierte porphyrine
JP5008793B2 (ja) * 1998-08-28 2012-08-22 デスティニー ファーマ リミテッド ポルフィリン誘導体、光力学療法におけるそれらの使用およびそれらを含有する医療装置
JP4501128B2 (ja) 1999-01-25 2010-07-14 ナショナル ジュウィッシュ ヘルス 置換ポルフィリン
GB0001455D0 (en) * 2000-01-21 2000-03-15 Scotia Holdings Plc Porphyrins and related compounds
AU783640B2 (en) * 2000-06-26 2005-11-17 Wellcome Trust Limited, The Improvements in and relating to chromophores
KR100390771B1 (ko) * 2000-08-31 2003-07-10 한국화학연구원 광역학 치료(ｐｄｔ)용 광민감성 물질로 유용한 포르피린유도체
CA2436245C (en) * 2001-01-19 2013-04-23 National Jewish Medical And Research Center Medicament for protection in radiotherapy
AU2002312194B8 (en) 2001-06-01 2008-05-15 Aeolus Sciences, Inc. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
JP4529344B2 (ja) * 2002-06-03 2010-08-25 ニプロ株式会社 腫瘍組織の酸素濃度を上昇させるためのポルフィリン酸素輸液製剤
AU2003237500A1 (en) 2002-06-07 2003-12-22 Duke University Substituted porphyrins
EP2300003B1 (en) 2008-05-23 2014-03-05 National Jewish Health Compounds for use in treating injury associated with exposure to an alkylating species
EP2230242B1 (en) 2009-03-16 2013-08-14 Johannes Kepler Universität Synthesis of new asymmetrically meso-substituted water-soluble porphyrins acting as cytostatic agents
WO2011161065A1 (en) 2010-06-25 2011-12-29 Fundação Padre Antonio Vieira Macrocyclic tetrapyrrolic compound of the family of porphyrins, chlorins and bacteriochlorins as photosensitizers for photodynamic therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988436A (en) * 1974-02-11 1976-10-26 Carnation Company Sunscreening method using rice bran oil
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
JPS5587793A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Carcinostatic meso-tetra(p-carboxyphenyl)porphine derivative
JPS5587792A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Meso-tetra(p-carboxyphenyl)porphine derivative
JPS5787793A (en) * 1980-11-19 1982-06-01 Mitsubishi Heavy Ind Ltd Hydraulic steering apparatus for vessel
US4386087A (en) * 1981-07-01 1983-05-31 Research Foundation Of The City University Of New York N-Substituted metalloporphyrins as anti-tumor agents against PS-P-388(P388) leukemia in animals
JPH0249315B2 (ja) * 1981-08-17 1990-10-29 Seisan Kaihatsu Kagaku Kenkyusho Sosuiseichikankiojusuruhorufuirinoyobisonosakutai
AU549719B2 (en) * 1981-09-08 1986-02-06 Metalaser Technologies Limited Photoradiation method and arrangement
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents

Also Published As

Publication number Publication date
EP0186962B1 (en) 1989-04-12
AU578329B2 (en) 1988-10-20
ATE42037T1 (de) 1989-04-15
US4837221A (en) 1989-06-06
EP0186962A1 (en) 1986-07-09
JPS61130220A (ja) 1986-06-18
AU5036785A (en) 1986-06-05
IE58500B1 (en) 1993-10-06
IE852906L (en) 1986-05-26
ZA858986B (en) 1986-08-27
CA1257202A (en) 1989-07-11
GB8429845D0 (en) 1985-01-03
JPH0653665B2 (ja) 1994-07-20
DE3569332D1 (en) 1989-05-18

Similar Documents

Publication Publication Date Title
DE3569332D1 (en) Porphyrins and cancer treatment
HK129693A (en) Porphyrins and medicaments for cancer treatment
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
BR9205645A (pt) Derivados de 2,4-diaminoquinazolinas para aumentar a atividade antitumoral
IN170909B (xx)
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
HU911193D0 (en) Conjugates consisting of difluor-glutaminic acid and pholates as well as antipholates being suitable for treating pneosplastic illnesses
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
O'Donnell et al. Intensive induction chemotherapy for small cell anaplastic carcinoma of the lung
IL97855A0 (en) Bromide containing pharmaceutical compositions for treatment of psoriasis
GR3026105T3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
AU639804B2 (en) Novel platinum (ii) complex and drug for treating malignant tumor
EP0333831A4 (en) USE OF METALLOPORPHYRIN TO REVERSE THE TOXIC EFFECT OF TUMOR THERAPY.
ATE120447T1 (de) Polyamin-derivate als antineoplastische mittel.
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ZA841850B (en) 2'-desoxyoxanosine,a process for the preparation thereof and its use as a medicament
MX9102181A (es) Iminobenzodiazepina para el tratamiento de desordenes del sueno

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)